As a prototypical DDX protein, DDX17 has been demonstrated to function as a transcriptional co-factor to facilitate chromatin accessibility and transcriptional activity at target gene loci, thereby augmenting the malignant potential of various malignancies, including lung, breast and liver cancer 14, 15, 33. This evidence concerns the gene AKR1C3 and liver cancer.